Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report
{{output}}
Background: Thanatophoric dysplasia type 1 (TD1) is the most severe form of FGFR3-related skeletal dysplasia, with high perinatal mortality and no approved pharmacologic therapies. Vosoritide, a C-type natriuretic peptide analogu... ...